Indefinite Delivery Contract SPE2DB25D9301

The Defense Logistics Agency (DLA) awarded an Indefinite Delivery Contract (IDC) with a ceiling value of $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide.

The single-award IDC, which runs through November 30, 2026, covers a comprehensive array of pharmaceuticals, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The products supplied under this contract include common medications like antibiotics and pain relievers, as well as specialized drugs such as flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, contraceptives, oncology drugs, and specialty medications. The majority of these items are delivered to the DLA's Medical Supply Chain division, which then distributes them to various Department of Defense healthcare facilities globally. This IDC complements DMS Pharmaceutical Group's existing prime vendor contracts for direct pharmaceutical distribution and pharmacy services to the Department of Defense, solidifying the company's role as a critical supplier in the federal pharmaceutical supply chain.